279 related articles for article (PubMed ID: 28534428)
1. Clinimetric validity of the Trail Making Test Czech version in Parkinson's disease and normative data for older adults.
Bezdicek O; Stepankova H; Axelrod BN; Nikolai T; Sulc Z; Jech R; Růžička E; Kopecek M
Clin Neuropsychol; 2017; 31(sup1):42-60. PubMed ID: 28534428
[TBL] [Abstract][Full Text] [Related]
2. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
[TBL] [Abstract][Full Text] [Related]
3. Czech version of the Trail Making Test: normative data and clinical utility.
Bezdicek O; Motak L; Axelrod BN; Preiss M; Nikolai T; Vyhnalek M; Poreh A; Ruzicka E
Arch Clin Neuropsychol; 2012 Dec; 27(8):906-14. PubMed ID: 23027441
[TBL] [Abstract][Full Text] [Related]
4. The Prague Stroop Test: Normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson's disease.
Bezdicek O; Lukavsky J; Stepankova H; Nikolai T; Axelrod BN; Michalec J; Růžička E; Kopecek M
J Clin Exp Neuropsychol; 2015; 37(8):794-807. PubMed ID: 26313510
[TBL] [Abstract][Full Text] [Related]
5. Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.
Bezdicek O; Michalec J; Nikolai T; Havránková P; Roth J; Jech R; Růžička E
Dement Geriatr Cogn Disord; 2015; 39(5-6):303-11. PubMed ID: 25792240
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
[TBL] [Abstract][Full Text] [Related]
7. A parsimonious scoring and normative calculator for the Parkinson's disease mild cognitive impairment battery.
Bezdicek O; Sulc Z; Nikolai T; Stepankova H; Kopecek M; Jech R; Růžička E
Clin Neuropsychol; 2017; 31(6-7):1231-1247. PubMed ID: 28276860
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of the Chinese Version of the Trail-Making Test for Screening Cognitive Impairment.
Wei M; Shi J; Li T; Ni J; Zhang X; Li Y; Kang S; Ma F; Xie H; Qin B; Fan D; Zhang L; Wang Y; Tian J
J Am Geriatr Soc; 2018 Jan; 66(1):92-99. PubMed ID: 29135021
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of glial cell line-derived neurotrophic factor and multiple neurotransmitters: In relation to cognitive performance in Parkinson's disease with mild cognitive impairment.
Liu Y; Tong S; Ding L; Liu N; Gao D
Int J Geriatr Psychiatry; 2020 Feb; 35(2):153-162. PubMed ID: 31650626
[TBL] [Abstract][Full Text] [Related]
10. Brief Visuospatial Memory Test-Revised: normative data and clinical utility of learning indices in Parkinson's disease.
Havlík F; Mana J; Dušek P; Jech R; Růžička E; Kopeček M; Georgi H; Bezdicek O
J Clin Exp Neuropsychol; 2020 Dec; 42(10):1099-1110. PubMed ID: 33198558
[No Abstract] [Full Text] [Related]
11. Demographic characteristics and normative observations for derived-trail making test indices.
Drane DL; Yuspeh RL; Huthwaite JS; Klingler LK
Neuropsychiatry Neuropsychol Behav Neurol; 2002 Mar; 15(1):39-43. PubMed ID: 11877550
[TBL] [Abstract][Full Text] [Related]
12. Trail Making Test errors in normal aging, mild cognitive impairment, and dementia.
Ashendorf L; Jefferson AL; O'Connor MK; Chaisson C; Green RC; Stern RA
Arch Clin Neuropsychol; 2008 Mar; 23(2):129-37. PubMed ID: 18178372
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Motor and Cognitive Performance in People with Parkinson's Disease Using Instrumented Trail-Making Test.
Mishra RK; Park C; Zhou H; Najafi B; Thrasher TA
Gerontology; 2022; 68(2):234-240. PubMed ID: 33940574
[TBL] [Abstract][Full Text] [Related]
14. Trail Making Tests A and B: regression-based normative data for Quebec French-speaking mid and older aged adults.
St-Hilaire A; Parent C; Potvin O; Bherer L; Gagnon JF; Joubert S; Belleville S; Wilson MA; Koski L; Rouleau I; Hudon C; Macoir J
Clin Neuropsychol; 2018; 32(sup1):77-90. PubMed ID: 29726305
[TBL] [Abstract][Full Text] [Related]
15. D-KEFS trail making test as an embedded performance validity measure.
Jurick SM; Eglit GML; Delis DC; Bondi MW; Jak AJ
J Clin Exp Neuropsychol; 2022 Feb; 44(1):62-72. PubMed ID: 35603485
[TBL] [Abstract][Full Text] [Related]
16. Digital trail making test-black and white: Normal vs MCI.
Simfukwe C; Youn YC; Kim SY; An SS
Appl Neuropsychol Adult; 2022; 29(6):1296-1303. PubMed ID: 33529537
[TBL] [Abstract][Full Text] [Related]
17. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
Cammisuli DM; Sportiello MT
Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
[TBL] [Abstract][Full Text] [Related]
18. How effective is the Trail Making Test (Parts A and B) in identifying cognitively impaired drivers?
Dobbs BM; Shergill SS
Age Ageing; 2013 Sep; 42(5):577-81. PubMed ID: 23896609
[TBL] [Abstract][Full Text] [Related]
19. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
